Search

Search Constraints

You searched for: Author/Creator Kohn, Elise C

Search Results

1. Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial. Issue 7 (July 2020)

2. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Issue 8 (August 2022)

3. Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting Report. (27th March 2020)

4. Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study. Issue 2 (February 2018)